Johnson & Johnson Stock Brushes Off Beat-and-Raise

Company Performance - Johnson & Johnson (NYSE: JNJ) stock is down 1.2% to $188.54 despite beating earnings and revenue expectations for Q3 [1] - The company announced a spin-off of its orthopedics business, raised its full-year forecast, and issued a dividend for the fiscal fourth quarter [1] Stock Movement - Shares are taking a breather from their record high of $192.10 on October 9, following a bounce off long-term support at the 40-day moving average [2] - The stock has a 32% year-to-date lead and appears to have found support around the $185 region [2] Options Market Activity - Calls are outpacing puts, but options traders are exhibiting more pessimism than usual, with the stock's 50-day put/call volume ratio higher than 80% of annual readings [3] - Options volume is running at triple the intraday average, with 10,000 calls and 5,143 puts exchanged, the most active being the October 192.50 call [4] Volatility and Pricing - Options are reasonably priced, with a Schaeffer's Volatility Index (SVI) of 21% ranking in the low 27th percentile of its annual range, indicating low volatility expectations [5] - Johnson & Johnson tends to outperform volatility expectations, as indicated by a Schaeffer's Volatility Scorecard (SVS) of 90 out of 100 [5]